The FDA has approved a first-of-its-kind eye drop that addresses a common vision condition. The once-daily drops will treat an age-related condition that causes blurry near vision. The drops are ...

The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration ...

For millions of adults, aging brings a familiar frustration: difficulty focusing on close-up objects such as books, smartphones, or small print. Traditionally, reading glasses or surgery have been the ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults with presbyopia. This age-related condition affects more than 100 million ...

For people with age-related blurry vision, once-a-day prescription eye drops offer a quick fix that lasts for up to 10 hours. Vizz (aceclidine ophthalmic solution) eye drops received FDA approval for ...

As people age, many develop presbyopia — age-related farsightedness that makes it hard to read things at close range — and may turn to reading glasses. But new research suggests another option may be ...

As people age, many develop presbyopia — age-related farsightedness that makes it hard to read things at close range — and may turn to reading glasses. But new research suggests another option may be ...

Trials of vision-improving substances are showing good results, though so far only two have been authorized for use in the United States. The Stats don’t lie: after age 65, most people will struggle ...